Niklas Mattsson

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz et al. · JAMA · 2020 · 1.4K citations · Full text

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton et al. · The Lancet Neurology · 2020 · 1.3K citations

Alzheimer's Disease, Dementia, Prospective Cohorts +11

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist et al. · Nature Medicine · 2020 · 1.2K citations

Neurodegenerative Diseases, Plasma P-tau181, Alzheimer's Disease +14

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

Niklas Mattsson · JAMA · 2009 · 1.1K citations

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

Niklas Mattsson, Ulf Andréasson, Henrik Zetterberg et al. · JAMA Neurology · 2017 · 1K citations · Full text